Centessa Pharmaceuticals: To Disclose The Number Of Ordinary Shares Of The Company (including In The Form Of American Depositary Shares) To Be Issued In Satisfaction Of The Contingent Value Rights, Which Was Determined On March 8, 2022, Regulation Fd Disclosure, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Centessa Pharmaceuticals plc
• Registration country
  United Kingdom
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***